AMN Healthcare Announces Third Quarter 2015 Results

Quarterly revenue increases to record high $383 million; reports adjusted EPS of $0.48 (GAAP EPS of $0.69)

Nov 04, 2015, 16:44 ET from AMN Healthcare Services, Inc.

SAN DIEGO, Nov. 4, 2015 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AHS), healthcare's leader and innovator in workforce solutions and staffing services, today announced third quarter 2015 financial results that exceeded the Company's guidance for revenue and adjusted EBITDA. Third quarter financial highlights are as follows:

Dollars in millions, except per share amounts.


Q3 2015

% Change

Q3 2014

YTD September 30, 2015

% Change YTD September 30, 2014

Revenue

$382.9

45%

$1,060.5

40%

Gross profit

$126.0

57%

$337.6

46%

Net income

$33.6

296%

$61.7

165%

Diluted EPS

$0.69

283%

$1.27

159%

Adjusted diluted EPS*

$0.48

140%

$1.17

95%

Adjusted EBITDA*

$45.6

109%

$118.3

79%


* See "Non-GAAP Measures" below for a discussion of our use of non-GAAP items and the table entitled "Supplemental Financial and Operating Data" for a reconciliation of non-GAAP items.

 

  • Demand continues at historic high levels, driving strong organic growth in all business segments.
  • Consolidated revenue increased 45% year-over-year, driven by organic growth of 29% and the remainder from acquisitions.
  • Gross margin of 32.9% represented an improvement of 250 basis points year-over-year and 150 basis points from the prior quarter.
  • Adjusted EBITDA margin of 11.9% reflected a 370 basis point year-over-year improvement, driven by both gross margin expansion and operating leverage.
  • Adjusted diluted EPS of $0.48 grew 140% year-over-year.
  • AMN Healthcare's differentiated strategy and focus on delivering a diverse portfolio of innovative workforce solutions and staffing services continues to drive industry leading performance.

"The AMN Healthcare team continues to deliver exceptional service and results to our clients amidst a strong demand environment, resulting in better than anticipated revenue and profitability growth in the third quarter," said Susan R. Salka, President and Chief Executive Officer of AMN Healthcare. "In addition to our focus on organic growth, we continue to expand AMN's capabilities, including our most recent acquisitions of The First String and Millican Solutions, which further bolster our physician executive and nurse leadership recruitment capabilities.  With a continuing robust demand outlook in all of our business segments, we remain focused on delivering superior value to our clients and healthcare professionals through continued expansion of our innovative workforce solutions and recruitment strategies."  

Third Quarter 2015 Results

For the third quarter of 2015, consolidated revenue was $383 million, an increase of 45% from the same quarter last year and 9% sequentially. Third quarter revenue for the Nurse and Allied Healthcare Staffing segment was $266 million, up 53% from the same quarter last year and 11% sequentially. Locum Tenens Staffing segment revenue in the third quarter was $102 million, an increase of 29% from the same quarter last year and up 4% sequentially. Third quarter Physician Permanent Placement Services segment revenue was $15 million, an increase of 29% from the same quarter last year and up 16% sequentially.

Third quarter gross margin of 32.9% was higher by 250 basis points than the same quarter last year and higher by 150 basis points sequentially. The year-over-year and sequential gross margin improvements were driven primarily by an increased revenue mix of our higher-margin workforce solutions businesses, along with a gross margin increase in the Locum Tenens Staffing segment.

SG&A expenses for the third quarter were $83 million, representing 21.7% of revenue, compared to 22.8% in the same quarter last year and 21.3% in the prior quarter. The improvement from the prior year was due to operating leverage on the revenue growth. The decline from the prior quarter was due to the prior quarter including a $3 million favorable professional liability adjustment.

Third quarter net income was $34 million and net income per diluted share was $0.69. Tax expense in the quarter included a $12 million favorable reversal of tax reserves. Excluding this tax adjustment, amortization of intangible assets, and acquisition and integration costs incurred during the quarter, adjusted net income per diluted share was $0.48. Third quarter adjusted EBITDA was $46 million, a year-over-year increase of 109% and sequential increase of 16%. Third quarter adjusted EBITDA margin of 11.9% represented a 370 basis point increase year-over-year and 70 basis point increase sequentially. 

At September 30, 2015, cash and cash equivalents totaled $14 million. Third quarter cash flow from operations was $22 million and capital expenditures were $7 million. The Company ended the third quarter with total debt outstanding of $214 million, with a leverage ratio of 1.5 to 1.

Business Trends and Outlook

The Company expects consolidated fourth quarter 2015 revenue of $385 to $390 million, reflecting continuing strong demand trends, slightly offset by normal seasonal declines in some businesses. Gross margin is expected to be approximately 32.0%. SG&A expenses as a percentage of revenue are expected to be approximately 21.5% to 22.0%. Adjusted EBITDA margin is expected to be approximately 10.5% to 11.0%.  

About AMN Healthcare

AMN Healthcare is the leader and innovator in healthcare workforce solutions and staffing services to healthcare facilities across the nation. AMN Healthcare's workforce solutions – including managed services programs, vendor management systems, recruitment process outsourcing and consulting services – enable providers to successfully reduce complexity, increase efficiency and improve patient outcomes within the rapidly evolving healthcare environment. The Company provides unparalleled access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, and many other healthcare settings. AMN Healthcare disseminates news and information about the Company through its website, which can be found at www.amnhealthcare.com.

Conference Call on November 5, 2015

AMN Healthcare Services, Inc.'s third quarter 2015 conference call will be held on Thursday, November 5, 2015, at 5:00 p.m. Eastern Time. A live webcast of the call can be accessed through AMN Healthcare's website at http://amnhealthcare.investorroom.com/presentations. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Interested parties may participate live via telephone by dialing (800) 230-1059 in the U.S. or (612) 234-9959 internationally. Following the conclusion of the call, a replay of the webcast will be available at the Company's website. A telephonic replay of the call will be available at 7:30 p.m. Eastern Time on November 5, 2015, and can be accessed until 11:59 p.m. Eastern Time on November 19, 2015, by calling (800) 475-6701 in the U.S. or (320) 365-3844 internationally, with access code 370640.

Non-GAAP Measures

This earnings release contains certain non-GAAP financial information, which the Company provides as additional information, and not as an alternative, to the Company's condensed consolidated financial statements presented in accordance with GAAP. These non-GAAP financial measures include (1) adjusted EBITDA, (2) adjusted EBITDA margin, and (3) adjusted diluted  EPS.  The Company provides such non-GAAP financial measures because management believes that they are useful both to management and investors as a supplement, and not as a substitute, when evaluating the Company's operating performance. Additionally, management believes that adjusted EBITDA, adjusted EBITDA margin and adjusted diluted EPS serve as industry-wide financial measures. The Company uses adjusted EBITDA for making financial decisions and allocating resources. The non-GAAP measures in this release are not in accordance with, or an alternative to, GAAP, and may be different from non-GAAP measures, or may be calculated differently than other similarly title-captioned non-GAAP measures, reported by other companies. They should not be used in isolation to evaluate the Company's performance.  A reconciliation of non-GAAP measures identified in this release, along with further detail about the use and limitations of certain of these non-GAAP measures, may be found below in the table entitled "Supplemental Financial and Operating Data" under the caption entitled "Reconciliation of Non-GAAP Items" or on the Company's website at http://amnhealthcare.investorroom.com/financialreports. Additionally, from time to time, additional information regarding non-GAAP financial measures, including pro forma measures, may be made available on the Company's website.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include expectations regarding fourth quarter 2015 strong demand trends, revenue, gross margin, SG&A expenses and adjusted EBITDA margin. The Company based these forward-looking statements on its current expectations, estimates and projections about future events and the industry in which it operates using information currently available to it. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are identified by words such as "believe," "anticipate," "expect," "intend," "plan," "will," "may," "estimates," variations of such words and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Factors that could cause actual results to differ from those implied by the forward-looking statements contained in this press release are set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2014 and its other periodic reports as well as the Company's current and other reports filed from time to time with the Securities and Exchange Commission. Be advised that developments subsequent to this press release are likely to cause these statements to become outdated with the passage of time.

Contact:
Amy C. Chang
Vice President, Investor Relations
866.861.3229

 

AMN Healthcare Services, Inc.

Condensed Consolidated Statements of Comprehensive Income

(in thousands, except per share amounts)

(unaudited)










Three Months Ended


Nine Months Ended


September 30,


June 30,


September 30,


2015

2014


2015


2015

2014

Revenue

$     382,859

$     264,584


$     350,144


$  1,060,513

$     756,378

Cost of revenue

256,850

184,278


240,026


722,954

524,957

Gross profit

126,009

80,306


110,118


337,559

231,421


32.9%

30.4%


31.4%


31.8%

30.6%

Operating expenses:








Selling, general and administrative

83,098

60,319


74,727


229,377

170,553


21.7%

22.8%


21.3%


21.6%

22.5%

Depreciation and amortization

5,304

4,086


5,232


15,631

11,916

Total operating expenses

88,402

64,405


79,959


245,008

182,469

Income from operations

37,607

15,901


30,159


92,551

48,952









Interest expense, net, and other

2,013

1,433


1,977


5,797

7,908

Income before income taxes

35,594

14,468


28,182


86,754

41,044

Income tax expense

1,947

5,969


12,312


25,028

17,722

Net income

$       33,647

$         8,499


$       15,870


$       61,726

$       23,322

Other comprehensive income (loss):








Foreign currency translation

54

75


(80)


42

29

Unrealized gain (loss) on cash flow hedge, net of income taxes

(367)

0


36


(331)

0

Other comprehensive income (loss)

(313)

75


(44)


(289)

29

Comprehensive income

$       33,334

$         8,574


$       15,826


$      61,437

$       23,351

Net income per common share:

 








Basic

$           0.71

$           0.18


$           0.33


$           1.30

$           0.50

Diluted

$           0.69

$           0.18


$           0.32


$           1.27

$           0.49









Weighted average common shares outstanding:








Basic

47,674

46,546


47,573


47,466

46,460

Diluted

48,978

48,122


48,863


48,737

47,959









 

 

AMN Healthcare Services, Inc.


Supplemental Financial and Operating Data


(dollars in thousands, except per share data)


(unaudited)
















Three Months Ended

Nine Months Ended



September  30,


June 30,


September 30,




2015


2014



2015



2015


2014


Revenue














  Nurse and allied healthcare staffing

$

266,279

$

174,292


$

240,016


$

735,341

$

503,636


  Locum tenens staffing


101,755


78,816



97,388



285,835


219,996


  Physician permanent placement services


14,825


11,476



12,740



39,337


32,746



$

382,859

$

264,584


$

350,144


$

1,060,513

$

756,378
















Reconciliation of Non-GAAP Items:




























Segment operating income (1)














  Nurse and allied healthcare staffing

$

40,873

$

21,279


$

35,395


$

108,169

$

63,283


  Locum tenens staffing


13,321


8,139



11,711



34,142


22,830


  Physician permanent placement services


4,555


2,756



3,277



11,103


7,074




58,749


32,174



50,383



153,414


93,187


   Unallocated corporate overhead


13,127


10,396



11,006



35,093


26,958


Adjusted EBITDA (2)


45,622


21,778



39,377



118,321


66,229


Adjusted EBITDA margin (3)


11.9%


8.2%



11.2%



11.2%


8.8%
















Depreciation and amortization


5,304


4,086



5,232



15,631


11,916


Share-based compensation


2,021


1,791



2,153



6,551


5,361


Acquisition and integration costs


690


0



1,833



3,588


0


Interest expense, net, and other


2,013


1,433



1,977



5,797


7,908


Income before income taxes


35,594


14,468



28,182



86,754


41,044


Income tax expense  


1,947


5,969



12,312



25,028


17,722


Net income

$

33,647

$

8,499


$

15,870


$

61,726

$

23,322






























GAAP diluted net income per share (EPS)

$

0.69

$

0.18


$

0.32


$

1.27

$

0.49


   Adjustments (net of tax):














   Debt extinguishment costs


0.00


0.00



0.00



0.00


0.04


   Amortization of intangible assets


0.03


0.02



0.04



0.11


0.07


   Acquistion and integration costs


0.01


0.00



0.02



0.04


0.00


   Income tax benefits


(0.25)


0.00



0.00



(0.25)


0.00


Adjusted diluted EPS (4)

$

0.48

$

0.20


$

0.38


$

1.17

$

0.60



Three Months Ended



Nine Months Ended



September 30,



June 30,



September 30,



2015


2014



2015



2015


2014

Gross Margin













   Nurse and allied healthcare staffing


32.0%


28.7%



30.7%



30.9%


28.9%

   Locum tenens staffing


30.7%


29.0%



29.2%



29.8%


29.5%

   Physician permanent placement services


65.4%


64.9%



63.1%



64.8%


63.8%














Operating Data:













Nurse and allied healthcare staffing













    Average healthcare professionals on assignment (5)


7,574


5,632



7,277



7,341


5,610

Locum tenens staffing













    Days filled (6)


59,267


49,982



59,844



173,371


143,780



























As of September 30,


As of June 30,






2015


2014



2015





Leverage ratio (7)


1.5


1.7



1.9


















 

AMN Healthcare Services, Inc.

Condensed Consolidated Balance Sheets

(dollars in thousands)

(unaudited)








September 30,


June 30,


December 31,


2015


2015


2014

Assets






Current assets:






Cash and cash equivalents

$       14,408


$       14,474


$       13,073

Accounts receivable, net

248,779


229,999


186,274

Accounts receivable, subcontractor

49,521


36,909


28,443

Deferred income taxes, net

18,378


27,362


27,330

Prepaid and other current assets

37,895


34,624


27,550

Total current assets

368,981


343,368


282,670

Restricted cash, cash equivalents and investments

25,425


21,698


19,567

Fixed assets, net

45,407


41,621


32,880

Other assets

46,634


45,210


39,895

Goodwill

201,444


197,325


154,387

Intangible assets, net

177,347


176,930


152,517







Total assets

$    865,238


$    826,152


$    681,916







Liabilities and stockholders' equity






Current liabilities:






Accounts payable and accrued expenses

$   113,152


$   101,578


$       78,993

Accrued compensation and benefits

88,492


76,581


67,995

Current portion of revolving credit facility

30,000


30,000


18,000

Current portion of notes payable

7,500


7,500


7,500

Deferred revenue

4,944


5,505


3,177

Other current liabilities

6,026


10,466


2,630

Total current liabilities

250,114


231,630


178,295













Revolving credit facility

45,500


55,500


0

Notes payable

131,250


133,125


136,875

Deferred income taxes, net

39,000


37,221


32,491

Other long-term liabilities

75,409


80,638


77,674

Total liabilities

541,273


538,114


425,335







Commitments and contingencies












Stockholders' equity

323,965


288,038


256,581







Total liabilities and stockholders' equity

$    865,238


$    826,152


$    681,916







AMN Healthcare Services, Inc.

Summary Condensed Consolidated Statements of Cash Flows

(dollars in thousands)

(unaudited)










Three Months Ended


Nine Months Ended


September 30,


June 30


September 30,


2015

2014 (8)


2015


2015

2014 (8)









Net cash provided by operating activities

$     21,950

$     15,452


$     25,000


$     55,637

$     22,493









Net cash used in investing activities

(10,768)

(4,511)


(9,516)


(105,634)

(10,320)









Net cash provided by (used in) financing activities

(11,302)

(6,854)


(12,563)


51,290

(18,119)









Effect of exchange rates on cash

54

75


(80)


42

29









Net increase (decrease) in cash and cash equivalents

(66)

4,162


2,841


1,335

(5,917)









Cash and cash equivalents at beginning of period

14,474

5,501


11,633


13,073

15,580









Cash and cash equivalents at end of period

$     14,408

$       9,663


$     14,474


$     14,408

$       9,663











(1)

Segment operating income represents net income plus interest expense (net of interest income) and other, income tax expense, depreciation and amortization, unallocated corporate overhead, acquisition and integration costs and share-based compensation.

(2)

Adjusted EBITDA represents net income plus interest expense (net of interest income) and other, income tax expense, depreciation and amortization, acquisition and integration costs and share-based compensation. Management believes that adjusted EBITDA provides an effective measure of the Company's results, as it excludes certain items that management believes are not indicative of the Company's operating performance and is a measure used in credit facilities. Adjusted EBITDA is not intended to represent cash flows for the period, nor has it been presented as an alternative to income from operations or net income as an indicator of operating performance. Although management believes that some of the items excluded from adjusted EBITDA are not indicative of the Company's operating performance, these items do impact the statement of comprehensive income, and management therefore utilizes adjusted EBITDA as an operating performance measure in conjunction with GAAP measures such as net income.

(3)

Adjusted EBITDA margin represents adjusted EBITDA divided by revenue.

(4)

Adjusted diluted EPS represents GAAP diluted EPS excluding the impact of 1) amortization of intangible assets; 2) acquisition and integration costs; and 3) other non-recurring costs, such as debt extinguishment costs and income tax benefits in connection with the reversal of reserves for uncertain tax positions, in each case, net of tax. Adjusted diluted EPS for the three and nine months ended September 30, 2014 have been restated to conform to the current year presentation. Management included this non-GAAP measure to provide investors and prospective investors with an alternative method for assessing the Company's operating results in a manner that is focused on its operating performance and to provide a more consistent basis for comparision between periods. However, investors and prospective investors should note that this non-GAAP measure involves judgment by management (in particular, judgment as to what is classified as a special item to be excluded from adjusted diluted EPS). Although management believes the items excluded from adjusted diluted EPS are not indicative of the Company's operating performance, these items do impact the statement of comprehensive income, and management therefore utilizes adjusted diluted EPS as an operating performance measure in conjunction with GAAP measures such as GAAP diluted EPS.

(5)

Average healthcare professionals on assignment represents the average number of nurse and allied healthcare professionals on assignment during the period presented.

(6)

Days filled is calculated by dividing the locum tenens hours filled during the period by eight hours.

(7)

Leverage ratio represents the ratio of the consolidated funded indebtedness (as calculated per the Company's credit agreement) at the end of the period to the consolidated adjusted EBITDA (as calculated per the Company's credit agreement) for the last twelve months.

(8)

Certain reclassifications have been made to the condensed consolidated statements of cash flows for the three and nine months ended September 30, 2014 to conform to the current year presentation.

 

 

SOURCE AMN Healthcare Services, Inc.



RELATED LINKS

http://www.amnhealthcare.com